Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Paramount Bed Holdings Co's cash to debt ratio for the quarter that ended in Sep. 2025 was 5.75.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Paramount Bed Holdings Cocould pay off its debt using the cash in hand for the quarter that ended in Sep. 2025.
The historical rank and industry rank for Paramount Bed Holdings Co's Cash-to-Debt or its related term are showing as below:
PBHDF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 2.2 Med: 5.75 Max: 9.99
Current: 5.75
During the past 13 years, Paramount Bed Holdings Co's highest Cash to Debt Ratio was 9.99. The lowest was 2.20. And the median was 5.75.
PBHDF's Cash-to-Debt is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.64
vs PBHDF: 5.75
Paramount Bed Holdings Co (OTCPK:PBHDF) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Paramount Bed Holdings Co Cash-to-Debt Related Terms
Paramount Bed Holdings Co Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paramount Bed Holdings Co Cash-to-Debt vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Paramount Bed Holdings Co's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paramount Bed Holdings Co (PBHDF) has a Cash-to-Debt of 5.75 as of Sep. 2025. This is near median its historical median of 5.75. Over the past decade, Paramount Bed Holdings Co's Cash-to-Debt has ranged from 2.20 to 9.99.
Is Paramount Bed Holdings Co's Cash-to-Debt too high?
Paramount Bed Holdings Co's current Cash-to-Debt of 5.75 is near median its 10-year median of 5.75. Over the past 10 years, this metric has ranged from a low of 2.20 to a high of 9.99. The Medical Devices & Instruments industry median Cash-to-Debt is 1.64. Paramount Bed Holdings Co's value of 5.75 is 250.6% above this industry median. Overall, Paramount Bed Holdings Co has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does Paramount Bed Holdings Co's Cash-to-Debt compare to ISRG and BDX?
Paramount Bed Holdings Co's Cash-to-Debt of 5.75 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash-to-Debt is 1.64. Paramount Bed Holdings Co's value of 5.75 is 250.6% above this benchmark. Historically, Paramount Bed Holdings Co's own Cash-to-Debt has ranged from 2.20 to 9.99 over the past decade. While the company's 10-year median is 5.75 vs. the industry median of 1.64, Paramount Bed Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.64, based on 819 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paramount Bed Holdings Co's current Cash-to-Debt of 5.75 is 250.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paramount Bed Holdings Co's current Cash-to-Debt is 5.75, which is near median its own 10-year median of 5.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paramount Bed Holdings Co stock overvalued right now?
Paramount Bed Holdings Co (PBHDF) has a current Cash-to-Debt of 5.75. The stock's GF Value™ is $16.33, compared to a current price of $19.74 — trading 20.9% above its estimated fair value. The current Cash-to-Debt is 5.75, which is near median its 10-year median of 5.75 and 250.6% above the Medical Devices & Instruments industry median of 1.64. Paramount Bed Holdings Co's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Paramount Bed Holdings Co (PBHDF), the current Cash-to-Debt is 5.75 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paramount Bed Holdings Co (PBHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Paramount Bed Holdings Co stock appears to be overvalued.
The current stock price of $19.74 is trading 20.9% above its estimated GF Value™ of $16.33.
Key valuation signals for PBHDF:
Cash-to-Debt: 5.75 (near median its 10-year median of 5.75)
GF Value™: $16.33 vs. price of $19.74 (20.9% above fair value)
Industry Position: 250.6% above the Medical Devices & Instruments median
No single metric tells the full story. See the PBHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.
90GF Score
Get the complete analysis for PBHDF
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBHDF has been successfully added to your 
